The ICRS Journal CARTILAGE is extremely proud to announce its ranking of 26 out of 76 journals in orthopaedics, with an Impact Factor of 2.000 (Source: 2016 Journal Citation Reports®, Clarivate Analytics, 2017).

This opportunity allows other physicians to come to Rush for a year and work in our facilities along with our faculty on clinical and basic science research. The year also allows for clinical shadowing time both in the office and operating room to help fellows understand the clinical implication of their work. Applications are accepted on a rolling basis for each year and can be sent at any time.

European Union (EU) regulators yesterday recommended approval of a third-generation transplant product of autologous cultured cartilage cells for repairing worn-out knees that doesn’t require any scaffold material.

We are pleased to announce the 3 successful candidates of the upcoming Travelling Fellowship 2017:

• UK Based location with international travel
• £40-50K per annum dependent on experience
• International Cartilage Repair Society Patient Registry and UK National Ligament Registry

KFAR SABA, Israel, Dec. 20, 2016 /PRNewswire/ — CartiHeal (2009) Ltd., developer of a cell-free, off-the-shelf implant for use in cartilage and osteochondral defects, announced today the FDA approval of the Investigational Device Exemption (IDE) application submitted by CartiHeal for their Agili-C™ implant, towards a PMA application.